Literature DB >> 5291965

[Essential senile bulimia].

A Castellani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5291965

Source DB:  PubMed          Journal:  Arch Ital Sci Med Trop Parassitol        ISSN： 0004-0282


× No keyword cloud information.
  12 in total

1.  Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents.

Authors:  Carsten Riether; Thomas Pabst; Sabine Höpner; Ulrike Bacher; Magdalena Hinterbrandner; Yara Banz; Rouven Müller; Markus G Manz; Walid H Gharib; David Francisco; Remy Bruggmann; Luc van Rompaey; Mahan Moshir; Tim Delahaye; Domenica Gandini; Ellen Erzeel; Anna Hultberg; Samson Fung; Hans de Haard; Nicolas Leupin; Adrian F Ochsenbein
Journal:  Nat Med       Date:  2020-06-29       Impact factor: 53.440

Review 2.  Emerging agents and regimens for treatment of relapsed and refractory acute myeloid leukemia.

Authors:  Longzhen Cui; Yan Liu; Yifan Pang; Tingting Qian; Liang Quan; Zhiheng Cheng; Yifeng Dai; Xu Ye; Ying Pang; Jinlong Shi; Xiaoyan Ke; Depei Wu; Lin Fu
Journal:  Cancer Gene Ther       Date:  2019-07-11       Impact factor: 5.987

3.  The role of EVI1 gene quantification in AML patients with 11q23/MLL rearrangement after allogeneic hematopoietic stem cell transplantation.

Authors:  Shuhui Jiang; Yi Fan; Yanglan Fang; Chang Hou; Jia Chen; Jiannong Cen; Huiying Qiu; Suning Chen; Yang Xu; Depei Wu
Journal:  Bone Marrow Transplant       Date:  2020-09-05       Impact factor: 5.483

4.  Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study.

Authors:  Yue Lu; Yan-Li Zhao; Jian-Ping Zhang; Min Xiong; Xing-Yu Cao; De-Yan Liu; Rui-Juan Sun; Zhi-Jie Wei; Jia-Rui Zhou; Dao-Pei Lu
Journal:  Ann Hematol       Date:  2020-11-24       Impact factor: 3.673

Review 5.  Towards precision medicine for AML.

Authors:  Hartmut Döhner; Andrew H Wei; Bob Löwenberg
Journal:  Nat Rev Clin Oncol       Date:  2021-05-18       Impact factor: 66.675

Review 6.  Impact of age, functional status, and comorbidities on quality of life and outcomes in elderly patients with AML: review.

Authors:  Kamel Laribi; Mohamad Sobh; David Ghez; Alix Baugier de Materre
Journal:  Ann Hematol       Date:  2021-04-02       Impact factor: 3.673

Review 7.  Therapeutic implications of menin inhibition in acute leukemias.

Authors:  Ghayas C Issa; Farhad Ravandi; Courtney D DiNardo; Elias Jabbour; Hagop M Kantarjian; Michael Andreeff
Journal:  Leukemia       Date:  2021-06-15       Impact factor: 11.528

8.  Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission.

Authors:  Roni Shouval; Myriam Labopin; David Bomze; Gabriela M Baerlocher; Saveria Capria; Didier Blaise; Mathias Hänel; Edouard Forcade; Anne Huynh; Riccardo Saccardi; Giuseppe Milone; Tsila Zuckerman; Péter Reményi; Jurjen Versluis; Jordi Esteve; Norbert Claude Gorin; Mohamad Mohty; Arnon Nagler
Journal:  Bone Marrow Transplant       Date:  2020-05-10       Impact factor: 5.483

9.  miR-29c&b2 encourage extramedullary infiltration resulting in the poor prognosis of acute myeloid leukemia.

Authors:  Yanyu Wei; Wei Lu; Yehua Yu; Yuanmei Zhai; Hezhou Guo; Shaoxin Yang; Chong Zhao; Yanjie Zhang; Jiali Liu; Yuhui Liu; Jian Fei; Jun Shi
Journal:  Oncogene       Date:  2021-04-22       Impact factor: 9.867

10.  Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantation.

Authors:  Huidong Guo; Ying-Jun Chang; Yan Hong; Lan-Ping Xu; Yu Wang; Xiao-Hui Zhang; Ming Wang; Huan Chen; Yu-Hong Chen; Feng-Rong Wang; Yu-Qian Sun; Chen-Hua Yan; Fei-Fei Tang; Xiao-Dong Mo; Kai-Yan Liu; Xiao-Jun Huang
Journal:  Cell Mol Immunol       Date:  2021-01-06       Impact factor: 11.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.